Clinical trial
A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks…
NCT00478881 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00478881 |
|---|---|
| Title | A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function |
| Official title | Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Vardenafil 10 mg Twice Daily to Assess the Effect on Urodynamics in Patients With Overactive Bladder (Detrusor Overactivity) |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Overactive Bladder, Detrusor Overactivity |
| Intervention type | Drug |
| Interventions | Vardenafil HCl (Levitra, BAY38-9456), Placebo |
| Enrollment | 397 |
| Start date | Aug 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | May 25, 2007 |
| Last update posted | Dec 11, 2014 |
| Countries | Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Netherlands, Poland, Portugal, Russia, Spain and 1 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: